Dispatches from the Biological Production Forum, Dublin

Sartorius: QbD for single-use systems could help assure quality

By Dan Stanton

- Last updated on GMT

Sartorius: QbD for single-use systems could help assure quality

Related tags: Management

Though industry has fully embraced single-use, manufacturers of such systems need to remove the risk of extractables and leachables and control the supply process according to Sartorius.

During a full first day at the 13th​ Annual Biological Production Forum in Dublin, Ireland, Sartorius Stedim Biotech said that whilst the benefits of single use systems have been well documented, problems still persist for suppliers of such containers – including the quality of bags, extractables and leachables and integrity testing – to ensure lot-to-lot consistency for the end user.

Luke Coxon, FMT Application Specialist at Sartorius used the example of bis(2,4-di-tert-butylphenyl)phosphate (bDtBPP), a leachable compound used in the construction of single-use bioprocess containers and discovered by Amgen to be detrimental to cell growth in a PDA Journal article last year​.

“What was found was during the gamma sterilization process there was a degradation compound that led to an impact on cell growth,”​ Coxon said. “This was very high profile, very high key and something we single-use suppliers and the industry as a whole weren’t really expecting.”

In order to ensure Sartorius’ films were not degraded in this way, the firm took proactive action to develop a design space for the output and temperature extrusion parameters, he continued.

This assurance has been further enhanced by Sartorius taking a quality by design (QbD) approach to the manufacture of its containers. Coxon spoke of developing key quality attributes by “looking at customers application use and ultimately wanting to ensure there is no adverse interaction with the product, the product is robust and it’s not going to lead to leaks and – sitting above all of that – wanting to ensure the product is going to be consistently supplied.”

Whilst a single-use bag’s barrier properties and the quality of the film is essential (though Coxon did speak of the trade off between flexibility and stiffness of the film), there are a number of processes in the manufacture of the systems done both internally and by external partners and Coxon said it was essential for a producer to keep full control of these.

“This leads to a high level of quality assurance, ensuring you have got consistently high quality product data, assurance of supply even in disaster scenarios, and also effective change control process”​ to limit impact of any changes.

Sartorius use third parties for resin cracking, film extrusion and gamma sterilization whilst the making of the bags, components and the single use assembly are done in-house, Coxon said.

Related news

Show more

Related products

show more

Protect your bulk filtration and dispense step

Protect your bulk filtration and dispense step

Parker Bioscience Filtration | 22-Jul-2019 | Data Sheet

Does your process need greater protection when the value of your product is at its highest?

At the bulk filtration and container fill stage,...

CadenceILC_610x343

Inline concentration improves process economics

Pall Biotech | 15-Jun-2018 | Case Study

Would you like to enhance your downstream process, increase production capacity and reduce costs? This case study application note demonstrates how implementing...

Featured eBook: Complex Protein Production

Featured eBook: Complex Protein Production

Catalent Pharma Solutions | 06-Mar-2018 | Technical / White Paper

Download the eBook written by Catalent experts to learn about innovative products and techniques for scale-up of complex biologics, get optimal cell culture...

Related suppliers

Follow us

Products

View more

Webinars